# 7 AEs, not related for 33 AEs while it was not reported for the remaining 3 AEs.

**Page range:** 45â€“46

```text
7 AEs, not related for 33 AEs while it was not reported for the remaining 3 AEs.
Please refer to Appendix 4 for detailed analysis and line listings of these cases.
Category C: The remaining 40/82 (48.8%) cases reporting fatal infection events
reported insufficient information regarding underlying medical conditions, concurrent
conditions, concomitant medications, event course details, drug-event latency,
laboratory findings, and/or autopsy findings to enable a comprehensive analysis.

46
Drug Safety Report No: 1132062
Of note, five13 of these 82 fatal cases were reported from study AcceleRET-Lung and
had already been discussed and presented in Section 3.2.1.1. The narratives along with
the case listings of the remaining 77 fatal cases are presented in Appendix 4.
```